Moreover, the expression of BVR-A, an enzyme involved in the reduction of biliverdin to the antioxidant bilirubin during heme degradation, and its oxidative and nitrosative modifications, were elevated in samples from the hippocampus of patients with AD in a previous study. This evidence concerns the gene BLVRA and Alzheimer disease.